List of Tables
Table 1. Global Pediatric Preventable Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Pediatric Preventable Vaccine Market Value by Application (2024-2030) & (US$ Million)
Table 3. Global Pediatric Preventable Vaccine Market Competitive Situation by Manufacturers in 2023
Table 4. Global Pediatric Preventable Vaccine Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Pediatric Preventable Vaccine Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Pediatric Preventable Vaccine Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Pediatric Preventable Vaccine Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Pediatric Preventable Vaccine Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Pediatric Preventable Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Pediatric Preventable Vaccine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Pediatric Preventable Vaccine, Product Type & Application
Table 12. Global Key Manufacturers of Pediatric Preventable Vaccine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Pediatric Preventable Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pediatric Preventable Vaccine as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Pediatric Preventable Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Pediatric Preventable Vaccine Sales by Region (2019-2024) & (K Units)
Table 18. Global Pediatric Preventable Vaccine Sales Market Share by Region (2019-2024)
Table 19. Global Pediatric Preventable Vaccine Sales by Region (2025-2030) & (K Units)
Table 20. Global Pediatric Preventable Vaccine Sales Market Share by Region (2025-2030)
Table 21. Global Pediatric Preventable Vaccine Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Pediatric Preventable Vaccine Revenue Market Share by Region (2019-2024)
Table 23. Global Pediatric Preventable Vaccine Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Pediatric Preventable Vaccine Revenue Market Share by Region (2025-2030)
Table 25. North America Pediatric Preventable Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Pediatric Preventable Vaccine Sales by Country (2019-2024) & (K Units)
Table 27. North America Pediatric Preventable Vaccine Sales by Country (2025-2030) & (K Units)
Table 28. North America Pediatric Preventable Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Pediatric Preventable Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Pediatric Preventable Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Pediatric Preventable Vaccine Sales by Country (2019-2024) & (K Units)
Table 32. Europe Pediatric Preventable Vaccine Sales by Country (2025-2030) & (K Units)
Table 33. Europe Pediatric Preventable Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Pediatric Preventable Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Pediatric Preventable Vaccine Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Pediatric Preventable Vaccine Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Pediatric Preventable Vaccine Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Pediatric Preventable Vaccine Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Pediatric Preventable Vaccine Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Pediatric Preventable Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Pediatric Preventable Vaccine Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Pediatric Preventable Vaccine Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Pediatric Preventable Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Pediatric Preventable Vaccine Revenue Market Share by Country (2019-2024)
Table 45. Middle East and Africa Pediatric Preventable Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East and Africa Pediatric Preventable Vaccine Sales by Country (2019-2024) & (K Units)
Table 47. Middle East and Africa Pediatric Preventable Vaccine Sales by Country (2025-2030) & (K Units)
Table 48. Middle East and Africa Pediatric Preventable Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East and Africa Pediatric Preventable Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Pediatric Preventable Vaccine Sales (K Units) by Type (2019-2024)
Table 51. Global Pediatric Preventable Vaccine Sales (K Units) by Type (2025-2030)
Table 52. Global Pediatric Preventable Vaccine Sales Market Share by Type (2019-2024)
Table 53. Global Pediatric Preventable Vaccine Sales Market Share by Type (2025-2030)
Table 54. Global Pediatric Preventable Vaccine Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Pediatric Preventable Vaccine Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Pediatric Preventable Vaccine Revenue Market Share by Type (2019-2024)
Table 57. Global Pediatric Preventable Vaccine Revenue Market Share by Type (2025-2030)
Table 58. Global Pediatric Preventable Vaccine Price (US$/Unit) by Type (2019-2024)
Table 59. Global Pediatric Preventable Vaccine Price (US$/Unit) by Type (2025-2030)
Table 60. Global Pediatric Preventable Vaccine Sales (K Units) by Application (2019-2024)
Table 61. Global Pediatric Preventable Vaccine Sales (K Units) by Application (2025-2030)
Table 62. Global Pediatric Preventable Vaccine Sales Market Share by Application (2019-2024)
Table 63. Global Pediatric Preventable Vaccine Sales Market Share by Application (2025-2030)
Table 64. Global Pediatric Preventable Vaccine Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Pediatric Preventable Vaccine Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Pediatric Preventable Vaccine Revenue Market Share by Application (2019-2024)
Table 67. Global Pediatric Preventable Vaccine Revenue Market Share by Application (2025-2030)
Table 68. Global Pediatric Preventable Vaccine Price (US$/Unit) by Application (2019-2024)
Table 69. Global Pediatric Preventable Vaccine Price (US$/Unit) by Application (2025-2030)
Table 70. Pfizer Inc. Company Information
Table 71. Pfizer Inc. Description and Business Overview
Table 72. Pfizer Inc. Pediatric Preventable Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Pfizer Inc. Pediatric Preventable Vaccine Product
Table 74. Pfizer Inc. Recent Developments/Updates
Table 75. Merck & Co., Inc. Company Information
Table 76. Merck & Co., Inc. Description and Business Overview
Table 77. Merck & Co., Inc. Pediatric Preventable Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Merck & Co., Inc. Pediatric Preventable Vaccine Product
Table 79. Merck & Co., Inc. Recent Developments/Updates
Table 80. GlaxoSmithKline plc (GSK) Company Information
Table 81. GlaxoSmithKline plc (GSK) Description and Business Overview
Table 82. GlaxoSmithKline plc (GSK) Pediatric Preventable Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. GlaxoSmithKline plc (GSK) Pediatric Preventable Vaccine Product
Table 84. GlaxoSmithKline plc (GSK) Recent Developments/Updates
Table 85. Sanofi Pasteur Company Information
Table 86. Sanofi Pasteur Description and Business Overview
Table 87. Sanofi Pasteur Pediatric Preventable Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Sanofi Pasteur Pediatric Preventable Vaccine Product
Table 89. Sanofi Pasteur Recent Developments/Updates
Table 90. Moderna, Inc. Company Information
Table 91. Moderna, Inc. Description and Business Overview
Table 92. Moderna, Inc. Pediatric Preventable Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Moderna, Inc. Pediatric Preventable Vaccine Product
Table 94. Moderna, Inc. Recent Developments/Updates
Table 95. Serum Institute of India Pvt. Company Information
Table 96. Serum Institute of India Pvt. Description and Business Overview
Table 97. Serum Institute of India Pvt. Pediatric Preventable Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Serum Institute of India Pvt. Pediatric Preventable Vaccine Product
Table 99. Serum Institute of India Pvt. Recent Developments/Updates
Table 100. Bharat Biotech International Company Information
Table 101. Bharat Biotech International Description and Business Overview
Table 102. Bharat Biotech International Pediatric Preventable Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Bharat Biotech International Pediatric Preventable Vaccine Product
Table 104. Bharat Biotech International Recent Developments/Updates
Table 105. CSL Limited (Seqirus) Company Information
Table 106. CSL Limited (Seqirus) Description and Business Overview
Table 107. CSL Limited (Seqirus) Pediatric Preventable Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. CSL Limited (Seqirus) Pediatric Preventable Vaccine Product
Table 109. CSL Limited (Seqirus) Recent Developments/Updates
Table 110. Emergent BioSolutions Inc. Company Information
Table 111. Emergent BioSolutions Inc. Description and Business Overview
Table 112. Emergent BioSolutions Inc. Pediatric Preventable Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Emergent BioSolutions Inc. Pediatric Preventable Vaccine Product
Table 114. Emergent BioSolutions Inc. Recent Developments/Updates
Table 115. Daiichi Sankyo Company Company Information
Table 116. Daiichi Sankyo Company Description and Business Overview
Table 117. Daiichi Sankyo Company Pediatric Preventable Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Daiichi Sankyo Company Pediatric Preventable Vaccine Product
Table 119. Daiichi Sankyo Company Recent Developments/Updates
Table 120. Novavax, Inc. Company Information
Table 121. Novavax, Inc. Description and Business Overview
Table 122. Novavax, Inc. Pediatric Preventable Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Novavax, Inc. Pediatric Preventable Vaccine Product
Table 124. Novavax, Inc. Recent Developments/Updates
Table 125. Sinovac Biotech Company Information
Table 126. Sinovac Biotech Description and Business Overview
Table 127. Sinovac Biotech Pediatric Preventable Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. Sinovac Biotech Pediatric Preventable Vaccine Product
Table 129. Sinovac Biotech Recent Developments/Updates
Table 130. Sinopharm Group Co., Company Information
Table 131. Sinopharm Group Co., Description and Business Overview
Table 132. Sinopharm Group Co., Pediatric Preventable Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 133. Sinopharm Group Co., Pediatric Preventable Vaccine Product
Table 134. Sinopharm Group Co., Recent Developments/Updates
Table 135. Johnson & Johnson (Janssen) Company Information
Table 136. Johnson & Johnson (Janssen) Description and Business Overview
Table 137. Johnson & Johnson (Janssen) Pediatric Preventable Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 138. Johnson & Johnson (Janssen) Pediatric Preventable Vaccine Product
Table 139. Johnson & Johnson (Janssen) Recent Developments/Updates
Table 140. AstraZeneca plc Company Information
Table 141. AstraZeneca plc Description and Business Overview
Table 142. AstraZeneca plc Pediatric Preventable Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 143. AstraZeneca plc Pediatric Preventable Vaccine Product
Table 144. AstraZeneca plc Recent Developments/Updates
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Pediatric Preventable Vaccine Distributors List
Table 148. Pediatric Preventable Vaccine Customers List
Table 149. Pediatric Preventable Vaccine Market Trends
Table 150. Pediatric Preventable Vaccine Market Drivers
Table 151. Pediatric Preventable Vaccine Market Challenges
Table 152. Pediatric Preventable Vaccine Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
Table 156. Authors List of This Report
List of Figures
Figure 1. Product Picture of Pediatric Preventable Vaccine
Figure 2. Global Pediatric Preventable Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Pediatric Preventable Vaccine Market Share by Type: 2023 & 2030
Figure 4. Live Vaccines Product Picture
Figure 5. Inactivated Vaccines Product Picture
Figure 6. Subunit Vaccines Product Picture
Figure 7. Mrna Vaccines Product Picture
Figure 8. Viral Vector Vaccines Product Picture
Figure 9. Global Pediatric Preventable Vaccine Market Value by Application (2024-2030) & (US$ Million)
Figure 10. Global Pediatric Preventable Vaccine Market Share by Application: 2023 & 2030
Figure 11. Bacterial Diseases
Figure 12. Virus Diseases
Figure 13. Global Pediatric Preventable Vaccine Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Pediatric Preventable Vaccine Market Size (2019-2030) & (US$ Million)
Figure 15. Global Pediatric Preventable Vaccine Sales (2019-2030) & (K Units)
Figure 16. Global Pediatric Preventable Vaccine Average Price (US$/Unit) & (2019-2030)
Figure 17. Pediatric Preventable Vaccine Report Years Considered
Figure 18. Pediatric Preventable Vaccine Sales Share by Manufacturers in 2023
Figure 19. Global Pediatric Preventable Vaccine Revenue Share by Manufacturers in 2023
Figure 20. Global 5 and 10 Largest Pediatric Preventable Vaccine Players: Market Share by Revenue in Pediatric Preventable Vaccine in 2023
Figure 21. Pediatric Preventable Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 22. Global Pediatric Preventable Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 23. North America Pediatric Preventable Vaccine Sales Market Share by Country (2019-2030)
Figure 24. North America Pediatric Preventable Vaccine Revenue Market Share by Country (2019-2030)
Figure 25. United States Pediatric Preventable Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Canada Pediatric Preventable Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Europe Pediatric Preventable Vaccine Sales Market Share by Country (2019-2030)
Figure 28. Europe Pediatric Preventable Vaccine Revenue Market Share by Country (2019-2030)
Figure 29. Germany Pediatric Preventable Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. France Pediatric Preventable Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. U.K. Pediatric Preventable Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Italy Pediatric Preventable Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Russia Pediatric Preventable Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Asia Pacific Pediatric Preventable Vaccine Sales Market Share by Region (2019-2030)
Figure 35. Asia Pacific Pediatric Preventable Vaccine Revenue Market Share by Region (2019-2030)
Figure 36. China Pediatric Preventable Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Japan Pediatric Preventable Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. South Korea Pediatric Preventable Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. India Pediatric Preventable Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Australia Pediatric Preventable Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. China Taiwan Pediatric Preventable Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Southeast Asia Pediatric Preventable Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Latin America Pediatric Preventable Vaccine Sales Market Share by Country (2019-2030)
Figure 44. Mexico Pediatric Preventable Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Brazil Pediatric Preventable Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Argentina Pediatric Preventable Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Colombia Pediatric Preventable Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Middle East and Africa Pediatric Preventable Vaccine Sales Market Share by Country (2019-2030)
Figure 49. Middle East and Africa Pediatric Preventable Vaccine Revenue Market Share by Country (2019-2030)
Figure 50. Turkey Pediatric Preventable Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Saudi Arabia Pediatric Preventable Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. UAE Pediatric Preventable Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Global Sales Market Share of Pediatric Preventable Vaccine by Type (2019-2030)
Figure 54. Global Revenue Market Share of Pediatric Preventable Vaccine by Type (2019-2030)
Figure 55. Global Pediatric Preventable Vaccine Price (US$/Unit) by Type (2019-2030)
Figure 56. Global Sales Market Share of Pediatric Preventable Vaccine by Application (2019-2030)
Figure 57. Global Revenue Market Share of Pediatric Preventable Vaccine by Application (2019-2030)
Figure 58. Global Pediatric Preventable Vaccine Price (US$/Unit) by Application (2019-2030)
Figure 59. Pediatric Preventable Vaccine Value Chain
Figure 60. Pediatric Preventable Vaccine Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
